Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve (i) The Standalone and Consolidated ....
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alkem Laboratories has informed exchanges that its Board meeting is scheduled for 28th May 2026. The meeting will consider and approve the Standalone and Consolidated Audited Financial Results for Q4 and the financial year ended 31st March 2026. Additionally, the Board will consider recommending a Final Dividend for FY 2025-26. The notice was issued on 19th May 2026 under SEBI LODR Regulations 29 and 33. This is a standard pre-result announcement filing and does not contain any financial figures or forward-looking statements.
This is a routine board meeting notice for quarterly and annual results. The mention of dividend consideration is typically positive for shareholders. Actual financial performance and dividend details will be known after the meeting. No immediate stock price impact from this notice alone.